Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,860 | 1,072 | 83.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,620 | 1 | 10.5% |
| Travel and Lodging | $1,238 | 3 | 5.0% |
| Education | $201.52 | 12 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,062 | 153 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $4,158 | 13 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $1,415 | 74 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,297 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,294 | 72 | $0 (2024) |
| Amgen Inc. | $1,190 | 74 | $0 (2024) |
| Novo Nordisk Inc | $1,094 | 91 | $0 (2024) |
| ABBVIE INC. | $966.77 | 72 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $869.87 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $730.55 | 53 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,901 | 71 | AstraZeneca Pharmaceuticals LP ($402.39) |
| 2023 | $1,921 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($560.15) |
| 2022 | $2,681 | 130 | Amgen Inc. ($427.01) |
| 2021 | $2,690 | 150 | Boehringer Ingelheim Pharmaceuticals, Inc. ($521.44) |
| 2020 | $1,865 | 129 | GlaxoSmithKline, LLC. ($262.26) |
| 2019 | $2,587 | 142 | Boehringer Ingelheim Pharmaceuticals, Inc. ($685.57) |
| 2018 | $6,221 | 177 | Synergy Pharmaceuticals Inc ($4,016) |
| 2017 | $5,054 | 207 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,321) |
All Payment Transactions
1,088 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: GI | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: PAIN | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 248 | 371 | $54,385 | $20,460 |
| 2022 | 8 | 323 | 497 | $66,260 | $23,695 |
| 2021 | 10 | 517 | 734 | $60,110 | $32,140 |
| 2020 | 13 | 643 | 962 | $74,620 | $41,678 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 110 | $26,400 | $10,070 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 102 | $16,830 | $5,480 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $6,715 | $2,380 | 35.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $1,710 | $1,367 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,750 | $849.25 | 48.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 51 | 98 | $980.00 | $314.58 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 143 | $34,320 | $12,378 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 106 | $17,490 | $6,236 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 22 | $7,150 | $2,215 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 40 | $2,800 | $1,348 | 48.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 39 | 40 | $1,200 | $802.64 | 66.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 46 | 108 | $1,080 | $349.23 | 32.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 19 | 22 | $1,100 | $195.17 | 17.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 16 | $1,120 | $171.39 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 230 | $28,700 | $16,859 | 58.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 71 | 95 | $8,075 | $3,419 | 42.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 66 | 94 | $5,875 | $2,999 | 51.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 53 | 68 | $6,800 | $2,564 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 26 | $4,290 | $2,480 | 57.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 17 | $1,700 | $1,280 | 75.3% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 49 | 49 | $1,470 | $974.11 | 66.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 48 | 48 | $1,440 | $936.48 | 65.0% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 44 | 84 | $840.00 | $330.12 | 39.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 22 | 23 | $920.00 | $297.88 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 166 | 355 | $35,525 | $19,507 | 54.9% |
About Dr. Ramon Sandoval, MD
Dr. Ramon Sandoval, MD is a Internal Medicine healthcare provider based in Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316032014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramon Sandoval, MD has received a total of $24,920 in payments from pharmaceutical and medical device companies, with $1,901 received in 2024. These payments were reported across 1,088 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($20,860).
As a Medicare-enrolled provider, Sandoval has provided services to 1,731 Medicare beneficiaries, totaling 2,564 services with total Medicare billing of $117,974. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Paterson, NJ
- Active Since 10/04/2006
- Last Updated 02/08/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316032014
Products in Payments
- Trulance (Drug) $4,158
- JARDIANCE (Drug) $3,249
- PRADAXA (Drug) $1,190
- Linzess (Drug) $760.60
- VRAYLAR (Drug) $731.61
- FARXIGA (Drug) $707.68
- Kerendia (Drug) $660.19
- TRELEGY ELLIPTA (Drug) $510.74
- EVENITY (Biological) $509.39
- SOLIQUA (Drug) $459.10
- Tymlos (Biological) $414.05
- ENTRESTO (Drug) $413.85
- JANUVIA (Drug) $377.94
- Ozempic (Drug) $349.96
- Victoza (Drug) $321.35
- AFREZZA (Drug) $316.05
- XIFAXAN (Drug) $300.00
- Otezla (Drug) $297.55
- SOLIQUA 100/33 (Biological) $290.69
- TRULICITY (Drug) $282.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paterson
Mr. Luis Luna, Md, MD
Internal Medicine — Payments: $16,210
Dr. Juan Desueza, M.d, M.D
Internal Medicine — Payments: $15,083
Dr. Henry Sherman, M.d, M.D
Internal Medicine — Payments: $11,678
Dr. Gammal Hassanien, Do, DO
Internal Medicine — Payments: $9,502
Mohamed Dahhan, M.d, M.D
Internal Medicine — Payments: $7,770
Hiren Patel, M.d, M.D
Internal Medicine — Payments: $7,677